-
1Academic Journal
المؤلفون: Musacchio N., Zilich R., Masi D., Baccetti F., Nreu B., Bruno Giorda C., Guaita G., Morviducci L., Muselli M., Ozzello A., Pisani F., Ponzani P., Rossi A., Santin P., Verda D., Di Cianni G., Candido R.
المساهمون: N. Musacchio, R. Zilich, D. Masi, F. Baccetti, B. Nreu, C. Bruno Giorda, G. Guaita, L. Morviducci, M. Muselli, A. Ozzello, F. Pisani, P. Ponzani, A. Rossi, P. Santin, D. Verda, G. Di Cianni, R. Candido
مصطلحات موضوعية: Artificial intelligence, HbA1c, Machine learning, Metformin failure, Metformin monotherapy, Therapeutic inertia, Type 2 diabetes, Settore MED/13 - Endocrinologia
Relation: info:eu-repo/semantics/altIdentifier/pmid/39059083; volume:190; firstpage:1; lastpage:10; numberofpages:10; journal:INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS; https://hdl.handle.net/2434/1085468; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85199401881
-
2Academic Journal
المؤلفون: Aloufi, Mohammed, Makhlouta, Abdullatif, Alsibaee, Ahmad, Zaknoun, Naim, Aljohani, Razan, Mohammed, Moneer, Alotaibi, Asma, Alahamdi, Ghassan, Alkurdi, Abdullah A.
المصدر: International Journal of Research in Medical Sciences; Vol. 11 No. 7 (2023): July 2023; 2401-2407 ; 2320-6012 ; 2320-6071
مصطلحات موضوعية: Type 2 diabetes, Metformin monotherapy, HbA1c, First-line therapy
وصف الملف: application/pdf
Relation: https://www.msjonline.org/index.php/ijrms/article/view/12387/7906; https://www.msjonline.org/index.php/ijrms/article/view/12387
-
3Academic Journal
المؤلفون: Moumita Hazra
المصدر: International Journal of Toxicological and Pharmacological Research, 12(3), 35-43, (2022-03-30)
مصطلحات موضوعية: Comparative Pharmacovigilance, Glycaemic Stabilisation Rate, Drug Safety Levels, Metformin Monotherapy, Metformin Combination Therapies, Anti-Diabetic Treatment
Relation: https://doi.org/10.5281/zenodo.12508682; https://doi.org/10.5281/zenodo.12508683; oai:zenodo.org:12508683; http://impactfactor.org/PDF/IJTPR/12/IJTPR,Vol12,Issue3,Article5.pdf
-
4Academic Journal
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014
-
5Academic Journal
المؤلفون: Vitarani Dwi Ananda Ningrum, Zullies Ikawati, Ahmad Hamim Sadewa, M. Robikhul Ikhsan, Yunilistiaingsih Yunilistiaingsih
المصدر: Jurnal Manajemen dan Pelayanan Farmasi, Vol 6, Iss 4, Pp 261-269 (2016)
مصطلحات موضوعية: DMT2, Faktor pasien, monoterapi metformin, respon glikemik, glycemic response, metformin monotherapy, patient-related factors, T2DM, Pharmacy and materia medica, RS1-441
وصف الملف: electronic resource
-
6
المؤلفون: Juliana C.N. Chan, Viswanathan Mohan, Stefano Del Prato, David R. Matthews, Chantal Mathieu, Sergio Vencio, Michael Stumvoll, Päivi M. Paldánius
المساهمون: HUS Children and Adolescents
المصدر: Diabetes Therapy
مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, VERIFY, Type 2 diabetes, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Quality of life, Randomized controlled trial, law, Glycaemic control, randomized trial, FAILURE, Medicine, Vildagliptin, POSITION STATEMENT, COMPLICATIONS, ASIA, BLOOD-GLUCOSE CONTROL, 3. Good health, Metformin, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, Combination therapy, education, 030209 endocrinology & metabolism, Endocrinology & Metabolism, 03 medical and health sciences, HYPERGLYCEMIA, Diabetes mellitus, MANAGEMENT, Internal Medicine, METFORMIN MONOTHERAPY, Intensive care medicine, EUROPEAN ASSOCIATION, Science & Technology, business.industry, INTENSIFICATION, Insulin, medicine.disease, CLINICAL INERTIA, 3121 General medicine, internal medicine and other clinical medicine, Commentary, metformin, business
وصف الملف: Print-Electronic
-
7Image
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014
-
8
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014
-
9Image
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014
-
10Image
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014
-
11Image
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014
-
12
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014
-
13
المؤلفون: Simon Horsburgh (8921756), Katrina Sharples (3639292), David Barson (8921753), Jiaxu Zeng (6475472), Lianne Parkin (4284712)
مصطلحات موضوعية: Biochemistry, Molecular Biology, Biotechnology, Developmental Biology, Infectious Diseases, Plant Biology, Chemical Sciences not elsewhere classified, New Zealand, reinitiated metformin monotherapy, 1 January 2006, 5 years, 1 year, healthcare-related factors, metformin monotherapy discontinuation, 31 December 2015. Discontinuation, type 2 diabetes mellitus, metformin monotherapy, reinitiation, metformin monotherapy use, 30 September 2014